6 completed, 1 active not recruiting, 1 recruiting. 8 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Completed 6, Active not recruiting 1, Recruiting 1 |
Follow ifetroban: new trials by email Literature Review of ifetroban trials Research Report on ifetroban
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF) Ifetroban Sodium, Placebo - Idiopathic Pulmonary Fibrosis | Phase 2 | Recruiting | Cumberland Pharmaceuticals | 128 | 2024-01-31 | 2026-09-02 |
| Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy Ifetroban, Placebo - Duchenne Muscular Dystrophy Cardiomyopathy, Cardiomyopathy, Dilated | Phase 2 | Completed | Cumberland Pharmaceuticals | 46 | 2020-10-19 | 2026-03-17 |
| Therapeutic Control of Aspirin-Exacerbated Respiratory Disease With Ifetroban Ifetroban, Placebo - Nasal Polyps, Asthma, Aspirin-Induced | Phase 2 | Completed | Brigham and Women's Hospital | 38 | 2018-04-26 | 2023-07-14 |
| Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD) Ifetroban Oral Capsule, Placebo Oral Capsule - Asthma, Aspirin-Induced | Phase 2 | Completed | Cumberland Pharmaceuticals | 54 | 2017-07-17 | 2024-07-10 |
| Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic Patients Ifetroban, Placebo - Portal Hypertension, Liver Cirrhosis | Phase 2 | Completed | Cumberland Pharmaceuticals | 30 | 2017-03-06 | 2022-01-19 |
| Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension Oral Ifetroban, Oral Placebo - Scleroderma, Diffuse, Scleroderma, Systemic | Phase 2 | Active not recruiting | Cumberland Pharmaceuticals | 34 | 2017-01-01 | 2026-09-02 |
| Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease Ifetroban, Oral Capsule, Placebo, Oral Capsule - Aspirin Exacerbated Respiratory Disease (AERD) | Phase 2 | Completed | Cumberland Pharmaceuticals | 19 | 2014-08-01 | 2017-05-15 |
| Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients Ifetroban Injection, Placebo - Hepatorenal Syndrome | Phase 2 | Completed | Cumberland Pharmaceuticals | 55 | 2011-10-01 | 2017-03-01 |
Asthma, Aspirin-Induced (3) · Autoimmune Diseases (1) · Cardiomyopathy, Dilated (1) · Connective Tissue Diseases (1) · Hepatorenal Syndrome (1) · Hypertension, Portal (1) · Idiopathic Pulmonary Fibrosis (1) · Liver Cirrhosis (1) · Nasal Polyps (1) · Pathologic Processes (1) · Rhinitis (1) · Scleroderma, Diffuse (1) · Scleroderma, Limited (1) · Scleroderma, Systemic (1) · Skin Diseases (1)
Cumberland Pharmaceuticals (7) · Brigham and Women's Hospital (1)
United States (8) · India (2)
Andrew White, MD (1) · Brendan McGuire, MD (1) · Don Rockey, MD (1) · Elliot Israel, MD (1) · Evan Brittain, MD (1) · Larry Markham, MD (1) · Todd Rice, MD, MSc (1)